Literature DB >> 2801842

Pelvic and paraaortic lymphocysts after radical surgery because of cervical and ovarian cancer.

E Petru1, K Tamussino, M Lahousen, R Winter, H Pickel, J Haas.   

Abstract

To determine the incidence and clinical import of lymphocysts after radical gynecologic surgery including lymphadenectomy, we reviewed the records of 173 patients with cervical cancer and 135 patients with ovarian cancer who were followed up by computed tomography. Lymphocysts were found in 35 (20%) and 43 (32%) of the patients, respectively. Patients with cervical cancer and positive lymph nodes had a significantly higher rate of lymphocyst formation than did those with negative nodes (29% versus 14%, respectively, p less than 0.02). Age, type of lymphadenectomy, volume of fluid furthered by postoperative drains, disease stage, and tumor histology were not related to lymphocyst development. We saw no complications strictly attributable to lymphocysts. The clinical import and treatment possibilities are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2801842     DOI: 10.1016/0002-9378(89)90757-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Pelvic mass in a young woman with a background of ovarian dysgerminoma: differential diagnosis.

Authors:  Emídio Vale-Fernandes; Fedra Rodrigues; Carla Monteiro; Paula Serrano
Journal:  BMJ Case Rep       Date:  2015-11-17

2.  An analysis of the risk factors and management of lymphocele after pelvic lymphadenectomy in patients with gynecologic malignancies.

Authors:  Hee Yeon Kim; Jae Wook Kim; Sung Hoon Kim; Young Tae Kim; Jae Hoon Kim
Journal:  Cancer Res Treat       Date:  2004-12-31       Impact factor: 4.679

3.  Lymphocele and ovarian cancer: risk factors and impact on survival.

Authors:  Tristan Gauthier; Catherine Uzan; Delphine Lefeuvre; Aminata Kane; Geoffroy Canlorbe; Fredéric Deschamps; Catherine Lhomme; Patricia Pautier; Philippe Morice; Sébastien Gouy
Journal:  Oncologist       Date:  2012-06-15

Review 4.  Lymphocele.

Authors:  K S Metcalf; K R Peel
Journal:  Ann R Coll Surg Engl       Date:  1993-11       Impact factor: 1.891

5.  What Are the Risk Factors for Lymphocyst Formation Apart From Lymphnode Dissection and Lymphnode Count in Gynecologic Malignancy?

Authors:  A Sahbaz; K Gungorduk; V Gulseren; I A Ozdemir; M Harma; M Harma; M Sancı
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-04       Impact factor: 2.915

Review 6.  Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in patients with gynaecological malignancies.

Authors:  Kittipat Charoenkwan; Chumnan Kietpeerakool
Journal:  Cochrane Database Syst Rev       Date:  2014-06-04

7.  Effective management of pelvic lymphocysts by laparoscopic marsupialization.

Authors:  F O Recio; S Ghamande; R E Hempling; M S Piver
Journal:  JSLS       Date:  1999 Apr-Jun       Impact factor: 2.172

8.  Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study.

Authors:  Yun Hwan Kim; Hyun Joo Shin; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2017-02-28       Impact factor: 4.401

9.  Predictors of Lymphoceles in Women Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecologic Cancer: A Retrospective Cohort Study.

Authors:  Hui-Hua Chen; Wan-Hua Ting; Ho-Hsiung Lin; Sheng-Mou Hsiao
Journal:  Int J Environ Res Public Health       Date:  2019-03-15       Impact factor: 3.390

10.  Bleomycin sclerotherapy for severe symptomatic and persistent pelvic lymphocele.

Authors:  Ana Sofia Fernandes; Antónia Costa; Raquel Mota; Vera Paiva
Journal:  Case Rep Obstet Gynecol       Date:  2014-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.